Therapeutic abortion. Complications following (induced) termination of pregnancy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant women with gestational age of 14-19 weeks and gravity of one to four Having a legal abortion license Absence of labor contractions Not having uterine myoma No previous history of uterine surgery Consent to participation in the study
Exclusion criteria
Exclusion criteria: Manifestation of possible complications Cancellation of continuing participation in the study Closeness and clinical examination within the first 24 hours Any problem for the mother which has an indication of immediate termination Prohibition of TNG use (including history of hypotension attacks, palpitations, or severe asthma biases)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of abortion. Timepoint: the first 24 hours after admission. Method of measurement: The frequency of abortion after admission.;From the commencement of intervention (reception of Perl) until the end of pregnancy. Timepoint: from the patient's arrival to the hospital until the abortion. Method of measurement: based on number of hours.;Duration of admission. Timepoint: up to 24 hours after medication use. Method of measurement: based on the number of hours recorded in the file.;Need for curettage. Timepoint: After admission in the event of the absence of complete embryo removal after the termination of drug dosage, induction or induction with oxytocin, curettage is carried out. Method of measurement: curettage surgery.;Medicine complications. Timepoint: after drug use commencement. Method of measurement: clinical complications. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences